Cinctive Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Cinctive Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-110,558	Closed	-$1.33M	–	573
2021 Q3	$1.33M	Sell	110,558 -75,612	-41%	-$1.1M	0.07%	359
2021 Q2	$3.94M	Buy	186,170 +13,707	+8%	+$330K	0.18%	169
2021 Q1	$4.84M	Sell	172,463 -11,361	-6%	-$335K	0.3%	131
2020 Q4	$4.78M	Buy	183,824 +41,560	+29%	+$1.24M	0.39%	91
2020 Q3	$5.29M	Buy	142,264 +47,357	+50%	+$1.88M	0.46%	71
2020 Q2	$4.87M	Buy	94,907 +73,556	+345%	+$3.08M	0.56%	51
2020 Q1	$673K	Buy	+21,351	New	+$1.13M	0.15%	173

Other funds holding ESPR

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Altium Capital Management New York $42M AUM

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return